Stocktoria
TransMedics Group, Inc. TMDX
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2019-05-02
TransMedics Group, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 59.9% | 59.4% | 63.8% | 69.8% | 67.4% |
| Operating margin | 17.9% | 8.5% | -11.9% | -33.6% | -125.6% |
| Net margin | 31.4% | 8.0% | -10.4% | -38.8% | -140.9% |
| FCF margin | 22.1% | -18.3% | -68.2% | -61.8% | -103.2% |
| Return on assets | 17.8% | 4.4% | -3.5% | -13.1% | -32.8% |
| Return on equity | 40.2% | 15.5% | -18.2% | -19.3% | -65.2% |
| Debt / equity | — | — | — | 0.31× | 0.52× |
| Current ratio | 7.14 | 8.30 | 9.30 | 10.66 | 5.11 |
| Revenue growth | 37.1% | 82.7% | 158.5% | 197.8% | 10.7% |
Source: SEC EDGAR filings · CIK 0001756262 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.